[Federal Register Volume 67, Number 85 (Thursday, May 2, 2002)]
[Notices]
[Pages 22163-22164]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-10954]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Research and Development Cooperativese Studies Evaluation 
Committee; Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under Public 
Law 92-463 (Federal Advisory Committee Act) that a meeting of the 
Research and Development, Cooperative Studies Evaluation Committee will 
be held at the Hyatt Regency Crystal City at Reagan National Airport, 
2799 Jefferson Davis Highway, Arlington, VA 22202, on May 16, 2002. The 
session is scheduled to begin at 8:00 a.m. and end at 3:00 p.m. The 
three new studies submitted for review are: Diiodothyroproprionic Acid, 
a Thyroid Analog to Treat Heart Failure, Phase II Trial; The Midwest 
Gulf War Cohort Study; and Ft. Devens Gulf War Veteran Cohort, A 
Longitudinal Study.
    The Committee advises the Chief Research and Development Officer 
through the Director of the Cooperative Studies Program on the 
relevance and feasibility of the studies, the adequacy of the 
protocols, and the scientific validity and propriety of technical 
details, including protection of human subjects.

[[Page 22164]]

    The meeting will be open to the public from 8:00 a.m. to 8:30 a.m. 
to discuss the general status of the program. Those who plan to attend 
should contact Ms. Denise Shorter, Staff Assistant, Department of 
Veterans Affairs (125D), 810 Vermont Avenue, NW., Washington, DC 20420, 
at (202) 565-7016.
    The meeting will be closed from 8:30 a.m. to 3:00 p.m. This portion 
of the meeting involves consideration of specific proposals in 
accordance with provisions set forth in section 10(d) of Public Law 92-
463, as amended by sections 5(c) of Public Law 94-409, and 5 U.S.C. 
552b(c)(6). During the closed session of the meeting, discussions and 
recommendations will deal with qualifications of personnel conducting 
the studies, staff and consultant critiques of research proposals, and 
similar documents, and the medical records of patients who are study 
subjects, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    By Direction of the Secretary.

    Dated: April 29, 2002.
Nora E. Egan,
Committee Management Officer.
[FR Doc. 02-10954 Filed 5-1-02; 8:45 am]
BILLING CODE 8320-01-M